Peter Hendricks will study psilocybin, a psychedelic compound, on its effects on smoking cessation. Researchers at the University of Alabama at Birmingham, Johns Hopkins University and New York University were awarded nearly $4 million in funding to study the efficacy of psilocybin, a classic psychedelic compound, in helping people quit smoking.